Tooling and Automation Engineer
About Paradromics
Brain-related illness is one of the last great frontiers in medicine, not because the brain is unknowable, but because it has been inaccessible. Paradromics is building a brain-computer interface (BCI) platform that records brain activity at the highest possible resolution: the individual neuron. AI algorithms then decode this massive amount of brain-data, enabling the seamless translation of thought into treatments.
Our first clinical application, the Connexus® BCI, will help people who are unable to speak, due to ALS, spinal cord injuries and stroke, to communicate independently through digital devices. However, the capabilities of our BCI platform go far beyond our first application. With the brain in direct communication with digital devices, we can leverage technology to transform how we treat conditions ranging from sensory and motor deficits to untreatable mental illness.
The Role
Paradromics is seeking a Tooling and Automation Engineer to define and build our end-to-end testing ecosystem across both hardware and software systems. In this role, you will develop a deep understanding of patient and caregiver use cases, as well as regulatory expectations, and translate those into scalable, reliable testing strategies.
You will own the design and operation of physical and automated test environments, ensuring our systems are thoroughly validated, auditable, and ready for clinical use.
Responsibilities
- Build and maintain physical test environments, including systems, jigs, and supporting hardware for automated testing
- Develop and manage end-to-end automated test frameworks across unit, integration, and system levels
- Enable secure remote access to testing environments, including environment checkout and usage workflows
- Implement access controls, logging, and change tracking for all test systems
- Audit and improve existing testing strategies, including introducing coverage reporting and increasing confidence in system validation
- Partner with regulatory teams to align testing approaches with FDA and internal requirements
- Develop automated validation and verification (V&V) processes for system functionality
Required Education
- Bachelor’s degree in Engineering, Computer Science, or a related technical field (or equivalent practical experience)
Required Qualifications
- 1+ year of experience building and maintaining physical integration test environments
- Experience writing unit and integration tests in Python
- Familiarity with tools used to create and manage testing environments, such as Docker, docker-compose, and CI/CD systems (e.g., GitHub Actions)
- Experience working across both hardware and software systems
Preferred Qualifications
- Experience with validation and verification (V&V) processes or platforms, especially in regulated environments
- Exposure to medical devices, aerospace, defense, or other highly regulated industries
- Prior leadership or ownership experience, with interest in growing into a team leadership role
- Familiarity with Rust
Paradromics is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, or national origin.
Top Skills
What We Do
ENABLING NEUROTECHNOLOGY Paradromics’ Brain-Computer Interface (BCI) platform records brain activity at the highest possible resolution: the individual neuron. Our AI algorithms decode this massive amount of brain-data, enabling the seamless translation of thought into treatments. THE MISSION Data-driven BCI-based technologies for brain health Our technology will help millions with unmet medical needs suffering from paralysis and movement disorders to chronic pain, addiction, depression and other mental health conditions. ABOUT Matt Angle Ph.D. (CEO) founded Paradromics to build a high-data-rate BCI platform capable of addressing critical unmet clinical needs. With early funding from the NIH and DARPA, the company developed its core neurotechnology and, by 2019, shifted focus to its first product: the Connexus® BCI. Connexus is designed to restore communication through text, synthesized speech, and computer control for people with severe motor impairments, including those caused by ALS, stroke, or spinal cord injury. Backed by two FDA Breakthrough Device Designations and a successful first-in-human recording in May 2025, Paradromics is now preparing to launch a clinical trial in late 2025 to evaluate the long-term safety and participant benefits of their first product, the Connexus BCI.









